Does PEMBROLIZUMAB Cause Cardiac failure? 675 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 675 reports of Cardiac failure have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.8% of all adverse event reports for PEMBROLIZUMAB.
675
Reports of Cardiac failure with PEMBROLIZUMAB
0.8%
of all PEMBROLIZUMAB reports
170
Deaths
392
Hospitalizations
How Dangerous Is Cardiac failure From PEMBROLIZUMAB?
Of the 675 reports, 170 (25.2%) resulted in death, 392 (58.1%) required hospitalization, and 87 (12.9%) were considered life-threatening.
Is Cardiac failure Listed in the Official Label?
Yes, Cardiac failure is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Cardiac failure?
SACUBITRIL\VALSARTAN (4,504)
FUROSEMIDE (1,841)
APIXABAN (1,575)
CYCLOPHOSPHAMIDE (1,514)
DOXORUBICIN (1,367)
ADALIMUMAB (1,278)
DEXAMETHASONE (1,271)
TREPROSTINIL (1,168)
BISOPROLOL (1,159)
LENALIDOMIDE (1,115)
Which PEMBROLIZUMAB Alternatives Have Lower Cardiac failure Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G